Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo
Authors:
- Huasheng LiangHLHuasheng Liang
- Yuhua ZhongYZYuhua Zhong
- Shaobi ZhouSZShaobi Zhou
- Liang PengLPLiang Peng
- 1 December 2011
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 313 (1) , 91-98
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Kisspeptin-10, a KISS1-Derived Decapeptide, Inhibits Tumor Angiogenesis by Suppressing Sp1-Mediated VEGF Expression and FAK/Rho GTPase ActivationCancer Research, 2009
- Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complicationsDiabetologia, 2009
- RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesisCarcinogenesis, 2008
- RAGE Activation by S100P in Colon Cancer Stimulates Growth, Migration, and Cell Signaling PathwaysDiseases of the Colon & Rectum, 2007
- VEGF as a Key Mediator of Angiogenesis in CancerOncology, 2005
- Differential effects of ?Advanced glycation endproducts? and ?-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5YJournal of Neural Transmission, 2004
- Differential effects between amphoterin and advanced glycation end products on colon cancer cellsInternational Journal of Cancer, 2003
- Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κBDiabetes, 2001
- Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastasesNature, 2000
- Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End ProductsJournal of Biological Chemistry, 1997